EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection

Lisa Oestereich iD, Helena Müller-Kräuter, Elisa Pallasch, Thomas Strecker iD

Viruses · 2023

DOI: 10.3390/v15071436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Lisa Oestereich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Bernhard-Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany. Hauptthemen laut MEDLINE: Lassa Fever. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Leibniz Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease.

Methods

We used chimeric Ifnar−/− C57BL/6 (Ifnar−/− Bl6) mice, a lethal LASV mouse model, to evaluate the protective efficacy of polyclonal antibodies purified from sera of rabbits hyperimmunized with virus-like particles displaying native-like LASV glycoprotein GP spikes.

Results

Polyclonal anti-LASV GP antibodies provided 100% protection against lethal LASV infection in a pre- and post-exposure treatment setting and prevented LASV disease. Treatment also significantly lowered viremia level and virus load in organs. When treatment was initiated at the onset of symptoms, the hyperimmune antibodies provided partial protection and increased the survival rate by 80%.

Conclusions

Our findings support the consideration of animal-derived hyperimmune antibodies targeting GP as an effective treatment option for highly pathogenic LASV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lassa FeverHumansAnimalsMiceRabbitsMice, Inbred C57BLLassa virusAntiviral AgentsAntibodies

Stichwörter der Autor:innen

Lassa feverLassa mammarenavirusarenavirusin vivo protectionneutralizing antibodiesvirus-like particle

Substanzen

Antiviral AgentsAntibodies

Autor:innen und Institutionen

  • Department of Virology, Bernhard-Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
  • German Center for Infectious Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, 20359 Hamburg, Germany.
  • Institute of Virology, Philipps University Marburg, 35043 Marburg, Germany.

ORCID-Profile: Lisa Oestereich, Thomas Strecker

Förderung

  • Deutsche Forschungsgemeinschaft
  • Leibniz Association

Zitieren

APA

Oestereich, L., Müller-Kräuter, H., Pallasch, E., & Strecker, T. (2023). Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection. Viruses. https://doi.org/10.3390/v15071436

Vancouver

Oestereich L, Müller-Kräuter H, Pallasch E, Strecker T. Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection. Viruses. 2023. doi:10.3390/v15071436

BibTeX
@article{Oestereich2023,
  author = {Oestereich, Lisa and Müller-Kräuter, Helena and Pallasch, Elisa and Strecker, Thomas},
  title = {Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15071436}
}
Kostenlos starten →